- Home
- MYND vs BRNS Comparison
MYND vs BRNS Comparison
Compare MYND & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- BRNS
- Stock Information
- Founded
- MYND 1998
- BRNS 2016
- Country
- MYND Cayman Islands
- BRNS United Kingdom
- Employees
- MYND N/A
- BRNS N/A
- Industry
- MYND Other Consumer Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MYND Real Estate
- BRNS Health Care
- Exchange
- MYND Nasdaq
- BRNS Nasdaq
- Market Cap
- MYND 85.8M
- BRNS 41.0M
- IPO Year
- MYND 2017
- BRNS 2021
- Fundamental
- Price
- MYND $1.88
- BRNS $1.11
- Analyst Decision
- MYND
- BRNS Strong Buy
- Analyst Count
- MYND 0
- BRNS 2
- Target Price
- MYND N/A
- BRNS $4.00
- AVG Volume (30 Days)
- MYND 118.6K
- BRNS 64.8K
- Earning Date
- MYND 02-05-2025
- BRNS 11-06-2024
- Dividend Yield
- MYND N/A
- BRNS N/A
- EPS Growth
- MYND N/A
- BRNS N/A
- EPS
- MYND N/A
- BRNS N/A
- Revenue
- MYND $357,050,000.00
- BRNS $14,969,000.00
- Revenue This Year
- MYND N/A
- BRNS $1,805.74
- Revenue Next Year
- MYND N/A
- BRNS N/A
- P/E Ratio
- MYND N/A
- BRNS N/A
- Revenue Growth
- MYND N/A
- BRNS 106.21
- 52 Week Low
- MYND $0.61
- BRNS $0.80
- 52 Week High
- MYND $6.95
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- MYND 47.68
- BRNS 54.91
- Support Level
- MYND $1.65
- BRNS $0.98
- Resistance Level
- MYND $2.60
- BRNS $1.25
- Average True Range (ATR)
- MYND 0.30
- BRNS 0.14
- MACD
- MYND -0.09
- BRNS 0.03
- Stochastic Oscillator
- MYND 21.91
- BRNS 68.82
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.